180 related articles for article (PubMed ID: 20562898)
1. Nitric oxide synthase 2 gene polymorphisms are associated with prostatic volume in Korean men with benign prostatic hyperplasia.
Yoo KH; Kim SK; Chung JH; Chang SG
Asian J Androl; 2010 Sep; 12(5):690-6. PubMed ID: 20562898
[TBL] [Abstract][Full Text] [Related]
2. Association of LTβR gene polymorphisms with prostate volume in benign prostatic hyperplasia in the Korean population.
Lee SH; Kim SK; Yoo KH; Chung JH; Chang SG
Genet Mol Res; 2015 Dec; 14(4):18607-15. PubMed ID: 26782510
[TBL] [Abstract][Full Text] [Related]
3. Association of IL10, IL10RA, and IL10RB polymorphisms with benign prostate hyperplasia in Korean population.
Yoo KH; Kim SK; Chung JH; Chang SG
J Korean Med Sci; 2011 May; 26(5):659-64. PubMed ID: 21532858
[TBL] [Abstract][Full Text] [Related]
4. Association between recurrent aphthous stomatitis and inheritance of a single-nucleotide polymorphism of the NOS2 gene encoding inducible nitric oxide synthase.
Karasneh JA; Darwazeh AM; Hassan AF; Thornhill M
J Oral Pathol Med; 2011 Oct; 40(9):715-20. PubMed ID: 21481004
[TBL] [Abstract][Full Text] [Related]
5. Promoter Polymorphism (rs12770170, -184C/T) of Microseminoprotein, Beta as a Risk Factor for Benign Prostatic Hyperplasia in Korean Population.
Ban JY; Yoo KH
Int Neurourol J; 2014 Jun; 18(2):63-7. PubMed ID: 24987558
[TBL] [Abstract][Full Text] [Related]
6. Genetic variants in 5p13.2 and 7q21.1 are associated with treatment for benign prostatic hyperplasia with the α-adrenergic receptor antagonist.
Qian X; Xu D; Liu H; Lin X; Yu Y; Kang J; Sheng X; Xu J; Zheng S; Xu D; Qi J
Aging Male; 2017 Dec; 20(4):250-256. PubMed ID: 28787260
[TBL] [Abstract][Full Text] [Related]
7. Association of NOS2 and NOS3 gene polymorphisms with susceptibility to type 2 diabetes mellitus and diabetic nephropathy in the Chinese Han population.
Chen F; Li YM; Yang LQ; Zhong CG; Zhuang ZX
IUBMB Life; 2016 Jul; 68(7):516-25. PubMed ID: 27192959
[TBL] [Abstract][Full Text] [Related]
8. Associations between polymorphisms in the steroid 5-alpha reductase type II (SRD5A2) gene and benign prostatic hyperplasia and prostate cancer.
Salam MT; Ursin G; Skinner EC; Dessissa T; Reichardt JK
Urol Oncol; 2005; 23(4):246-53. PubMed ID: 16018939
[TBL] [Abstract][Full Text] [Related]
9. SPINK1 Promoter Variants Are Associated with Prostate Cancer Predisposing Alterations in Benign Prostatic Hyperplasia Patients.
Winchester D; Ricks-Santi L; Mason T; Abbas M; Copeland RL; Beyene D; Jingwi EY; Dunston GM; Kanaan YM
Anticancer Res; 2015 Jul; 35(7):3811-9. PubMed ID: 26124326
[TBL] [Abstract][Full Text] [Related]
10. Prostate-specific antigen and 17-hydroxylase polymorphic genotypes in patients with prostate cancer and benign prostatic hyperplasia.
Gunes S; Bagci H; Sarikaya S; Bilen CY; Kara N
DNA Cell Biol; 2007 Dec; 26(12):873-8. PubMed ID: 17961073
[TBL] [Abstract][Full Text] [Related]
11. Association of vitamin D receptor gene polymorphism with prostate cancer and benign prostatic hyperplasia in a Japanese population.
Habuchi T; Suzuki T; Sasaki R; Wang L; Sato K; Satoh S; Akao T; Tsuchiya N; Shimoda N; Wada Y; Koizumi A; Chihara J; Ogawa O; Kato T
Cancer Res; 2000 Jan; 60(2):305-8. PubMed ID: 10667581
[TBL] [Abstract][Full Text] [Related]
12. The associations among eNOS G894T gene polymorphism, erectile dysfunction, and benign prostate hyperplasia-related lower urinary tract symptoms.
Lee YC; Wu WJ; Liu CC; Wang CJ; Li WM; Huang CH; Yeh HC; Ke HL; Huang SP
J Sex Med; 2009 Nov; 6(11):3158-65. PubMed ID: 19515207
[TBL] [Abstract][Full Text] [Related]
13. Association of benign prostate hyperplasia with polymorphisms in VDR, CYP17, and SRD5A2 genes among Lebanese men.
El Ezzi AA; Zaidan WR; El-Saidi MA; Al-Ahmadieh N; Mortenson JB; Kuddus RH
Asian Pac J Cancer Prev; 2014; 15(3):1255-62. PubMed ID: 24606449
[TBL] [Abstract][Full Text] [Related]
14. SRD5A1 and SRD5A2 are associated with treatment for benign prostatic hyperplasia with the combination of 5α-reductase inhibitors and α-adrenergic receptor antagonists.
Gu X; Na R; Huang T; Wang L; Tao S; Tian L; Chen Z; Jiao Y; Kang J; Zheng S; Xu J; Sun J; Qi J
J Urol; 2013 Aug; 190(2):615-9. PubMed ID: 23499746
[TBL] [Abstract][Full Text] [Related]
15. Immunogenetics of prostate cancer and benign hyperplasia--the potential use of an HLA-G variant as a tag SNP for prostate cancer risk.
Zambra FM; Biolchi V; de Cerqueira CC; Brum IS; Castelli EC; Chies JA
HLA; 2016 Feb; 87(2):79-88. PubMed ID: 26889902
[TBL] [Abstract][Full Text] [Related]
16. Association of CCL2, CCR2 and CCL5 genetic polymorphisms with the development and progression of benign prostatic hyperplasia.
Pang Y; Li H; Gong Y; Jing S; Peng C; Liu W; Zhao Y; Wang H; Kaushik D; Rodriguez R; Wang Z
Oncol Rep; 2019 Apr; 41(4):2491-2501. PubMed ID: 30816510
[TBL] [Abstract][Full Text] [Related]
17. Involvement of fibroblast growth factor receptor genes in benign prostate hyperplasia in a Korean population.
Park HJ; Kim SK; Kim JW; Lee SH; Yoo KH; Chung JH
Dis Markers; 2013; 35(6):869-75. PubMed ID: 24385678
[TBL] [Abstract][Full Text] [Related]
18. Glutathione S-transferase gene variants and risk of benign prostate hyperplasia in a North Indian population.
Konwar R; Manchanda PK; Chaudhary P; Nayak VL; Singh V; Bid HK
Asian Pac J Cancer Prev; 2010; 11(2):365-70. PubMed ID: 20843117
[TBL] [Abstract][Full Text] [Related]
19. Polygenic risk score predicting susceptibility and outcome of benign prostatic hyperplasia in the Han Chinese.
Hung SC; Chang LW; Hsiao TH; Lin GC; Wang SS; Li JR; Chen IC
Hum Genomics; 2024 May; 18(1):49. PubMed ID: 38778357
[TBL] [Abstract][Full Text] [Related]
20. Gastric cancer is associated with NOS2 -954G/C polymorphism and environmental factors in a Brazilian population.
Jorge YC; Duarte MC; Silva AE
BMC Gastroenterol; 2010 Jun; 10():64. PubMed ID: 20565800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
